Osteoporosis International

, Volume 16, Issue 6, pp 659–671 | Cite as

A model of osteoporosis impact in Switzerland 2000–2020

  • Matthias Schwenkglenks
  • Kurt Lippuner
  • Hans Jörg Häuselmann
  • Thomas D. Szucs
Original Article


The aim of our study was to develop a modeling framework suitable to quantify the incidence, absolute number and economic impact of osteoporosis-attributable hip, vertebral and distal forearm fractures, with a particular focus on change over time, and with application to the situation in Switzerland from 2000 to 2020. A Markov process model was developed and analyzed by Monte Carlo simulation. A demographic scenario provided by the Swiss Federal Statistical Office and various Swiss and international data sources were used as model inputs. Demographic and epidemiologic input parameters were reproduced correctly, confirming the internal validity of the model. The proportion of the Swiss population aged 50 years or over will rise from 33.3% in 2000 to 41.3% in 2020. At the total population level, osteoporosis-attributable incidence will rise from 1.16 to 1.54 per 1,000 person-years in the case of hip fracture, from 3.28 to 4.18 per 1,000 person-years in the case of radiographic vertebral fracture, and from 0.59 to 0.70 per 1,000 person-years in the case of distal forearm fracture. Osteoporosis-attributable hip fracture numbers will rise from 8,375 to 11,353, vertebral fracture numbers will rise from 23,584 to 30,883, and distal forearm fracture numbers will rise from 4,209 to 5,186. Population-level osteoporosis-related direct medical inpatient costs per year will rise from 713.4 million Swiss francs (CHF) to CHF946.2 million. These figures correspond to 1.6% and 2.2% of Swiss health care expenditures in 2000. The modeling framework described can be applied to a wide variety of settings. It can be used to assess the impact of new prevention, diagnostic and treatment strategies. In Switzerland incidences of osteoporotic hip, vertebral and distal forearm fracture will rise by 33%, 27%, and 19%, respectively, between 2000 and 2020, if current prevention and treatment patterns are maintained. Corresponding absolute fracture numbers will rise by 36%, 31%, and 23%. Related direct medical inpatient costs are predicted to increase by 33%; however, this estimate is subject to uncertainty due to limited availability of input data.


Economics Epidemiology Europe Modeling studies Osteoporosis Switzerland 



This study was supported by an unrestricted, educational grant from Merck Sharp & Dohme-Chibret AG, Glattbrugg, Switzerland.


  1. 1.
    Cummings SR, Melton LJ (2002) Epidemiology and outcomes of osteoporotic fractures. Lancet 359:1761–1767CrossRefPubMedGoogle Scholar
  2. 2.
    Seeley DG, Browner WS, Nevitt MC, Genant HK, Scott JC, Cummings SR (1991) Which fractures are associated with low appendicular bone mass in elderly women? The Study of Osteoporotic Fractures Research Group. Ann Intern Med 115:837–842PubMedGoogle Scholar
  3. 3.
    Dennison E, Cooper C (2000) Epidemiology of osteoporotic fractures. Horm Res 54 [Suppl 1]:58–63Google Scholar
  4. 4.
    Cooper C (1997) The crippling consequences of fractures and their impact on quality of life. Am J Med 103:12S–17SGoogle Scholar
  5. 5.
    Cooper C, Campion G, Melton LJ 3rd (1992) Hip fractures in the elderly: a world-wide projection. Osteoporos Int 2:285–289PubMedGoogle Scholar
  6. 6.
    Gullberg B, Johnell O, Kanis JA (1997) World-wide projections for hip fracture. Osteoporos Int 7:407–413PubMedGoogle Scholar
  7. 7.
    Sanders KM, Nicholson GC, Ugoni AM, Pasco JA, Seeman E, Kotowicz MA (1999) Health burden of hip and other fractures in Australia beyond 2000. Projections based on the Geelong Osteoporosis Study. Med J Aust 170:467–470PubMedGoogle Scholar
  8. 8.
    Chrischilles EA, Butler CD, Davis CS, Wallace RB (1991) A model of lifetime osteoporosis impact. Arch Intern Med 151:2026–2032CrossRefPubMedGoogle Scholar
  9. 9.
    Chrischilles E, Shireman T, Wallace R (1994) Costs and health effects of osteoporotic fractures. Bone 15:377–386CrossRefPubMedGoogle Scholar
  10. 10.
    Doherty DA, Sanders KM, Kotowicz MA, Prince RL (2001) Lifetime and five-year age-specific risks of first and subsequent osteoporotic fractures in postmenopausal women. Osteoporos Int 12:16–23CrossRefPubMedGoogle Scholar
  11. 11.
    Braithwaite RS, Col NF, Wong JB (2003) Estimating hip fracture morbidity, mortality and costs. J Am Geriatr Soc 51:364–370PubMedGoogle Scholar
  12. 12.
    Burge RT, King AB, Balda E, Worley D (2003) Methodology for estimating current and future burden of osteoporosis in state populations: application to Florida in 2000 through 2025. Value Health 6:574–583CrossRefPubMedGoogle Scholar
  13. 13.
    Lippuner K, von Overbeck J, Perrelet R, Bosshard H, Jaeger P (1997) Incidence and direct medical costs of hospitalizations due to osteoporotic fractures in Switzerland. Osteoporos Int 7:414–425PubMedGoogle Scholar
  14. 14.
    Lippuner K, Jaeger P (1998) Direkte Spitalkosten durch osteoporosebedingte Hüftfrakturen in der Schweiz heute und im Jahr 2020: Ein sozioökonomischer Alptraum. Schweiz Ärztezeitung 79:690–697Google Scholar
  15. 15.
    Meine J, Regazzoni P, Konig W (1993) Fractures of the proximal femur: rehabilitation and socioeconomic repercussions. Z Unfallchir Versicherungsmed 86:66–80PubMedGoogle Scholar
  16. 16.
    Sendi P, Palmer AJ (2000) Modeling the socioeconomic impact of osteoporosis-related hip fractures in Switzerland. Osteoporos Int 11:92–94CrossRefPubMedGoogle Scholar
  17. 17.
    Briggs A, Sculpher M (1998) An introduction to Markov modelling for economic evaluation. Pharmacoeconomics 13:397–409PubMedGoogle Scholar
  18. 18.
    Miller DK, Homan SM (1994) Determining transition probabilities: confusion and suggestions. Med Decis Making 14:52–58PubMedGoogle Scholar
  19. 19.
    Bundesamt für Statistik (2002) Szenarien zur Bevölkerungsentwicklung der Schweiz 2000–2060. Vollständiger Szenariensatz. Neuchâtel: Bundesamt für StatistikGoogle Scholar
  20. 20.
    Kanis JA, Johnell O, De Laet C, Jonsson B, Oden A, Ogelsby AK (2002) International variations in hip fracture probabilities: implications for risk assessment. J Bone Miner Res 17:1237–1244Google Scholar
  21. 21.
    The European Prospective Osteoporosis Study (EPOS) Group (2002) Incidence of vertebral fracture in Europe: results from the European Prospective Osteoporosis Study (EPOS). J Bone Miner Res 17:716–724PubMedGoogle Scholar
  22. 22.
    de Laet CE, Pols HA (2000) Fractures in the elderly: epidemiology and demography. Baillieres Best Pract Res Clin Endocrinol Metab 14:171–179CrossRefPubMedGoogle Scholar
  23. 23.
    Kanis JA, Johnell O, Oden A, Sembo I, Redlund-Johnell I, Dawson A, et al (2000) Long-term risk of osteoporotic fracture in Malmö. Osteoporos Int 11:669–674CrossRefPubMedGoogle Scholar
  24. 24.
    Black DM, Cooper C (2000) Epidemiology of fractures and assessment of fracture risk. Clin Lab Med 20:439–453PubMedGoogle Scholar
  25. 25.
    Ismail AA, Pye SR, Cockerill WC, Lunt M, Silman AJ, Reeve J, et al (2002) Incidence of limb fracture across Europe: results from the European Prospective Osteoporosis Study (EPOS). Osteoporos Int 13:565–571CrossRefPubMedGoogle Scholar
  26. 26.
    Melton LJ 3rd, Thamer M, Ray NF, Chan JK, Chesnut CH 3rd, Einhorn TA, et al (1997) Fractures attributable to osteoporosis: report from the National Osteoporosis Foundation. J Bone Miner Res 12:16–23PubMedGoogle Scholar
  27. 27.
    Trombetti A, Herrmann F, Hoffmeyer P, Schurch MA, Bonjour JP, Rizzoli R (2002) Survival and potential years of life lost after hip fracture in men and age-matched women. Osteoporos Int 13:731–737CrossRefPubMedGoogle Scholar
  28. 28.
    Ismail AA, O’Neill TW, Cooper C, Finn JD, Bhalla AK, Cannata JB, et al (1998) Mortality associated with vertebral deformity in men and women: results from the European Prospective Osteoporosis Study (EPOS). Osteoporos Int 8:291–297CrossRefPubMedGoogle Scholar
  29. 29.
    Cooper C, Atkinson EJ, Jacobsen SJ, O’Fallon WM, Melton LJ 3rd (1993) Population-based study of survival after osteoporotic fractures. Am J Epidemiol 137:1001–1005PubMedGoogle Scholar
  30. 30.
    Ensrud KE, Thompson DE, Cauley JA, Nevitt MC, Kado DM, Hochberg MC, et al (2000) Prevalent vertebral deformities predict mortality and hospitalization in older women with low bone mass. Fracture Intervention Trial Research Group. J Am Geriatr Soc 48:241–249PubMedGoogle Scholar
  31. 31.
    Center JR, Nguyen TV, Schneider D, Sambrook PN, Eisman JA (1999) Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet 353:878–882CrossRefPubMedGoogle Scholar
  32. 32.
    Melton LJ 3rd (2000) Excess mortality following vertebral fracture. J Am Geriatr Soc 48:338–339PubMedGoogle Scholar
  33. 33.
    Cooper C, Atkinson EJ, Kotowicz M, O’Fallon WM, Melton LJ 3rd (1992) Secular trends in the incidence of postmenopausal vertebral fractures. Calcif Tissue Int 51:100–104PubMedGoogle Scholar
  34. 34.
    Melton LJ 3rd, Lane AW, Cooper C, Eastell R, O’Fallon WM, Riggs BL (1993) Prevalence and incidence of vertebral deformities. Osteoporos Int 3:113–119PubMedGoogle Scholar
  35. 35.
    Bonjour JP, Burckhardt P, Dambacher M, Kraenzlin ME, Wimpfheimer C (1997) [Epidemiology of osteoporosis]. Schweiz Med Wochenschr 127:659–667PubMedGoogle Scholar
  36. 36.
    Pientka L (1996) Die ökonomische Bedeutung der Osteoporose in Deutschland. Deutsches Ärztemagazin 8:44–52Google Scholar
  37. 37.
    Schürch MA, Rizzoli R, Mermillod B, Vasey H, Michel JP, Bonjour JP (1996) A prospective study on socioeconomic aspects of fracture of the proximal femur. J Bone Miner Res 11:1935–1942PubMedGoogle Scholar
  38. 38.
    Dolan P, Torgerson DJ (1998) The cost of treating osteoporotic fractures in the United Kingdom female population. Osteoporos Int 8:611–617CrossRefPubMedGoogle Scholar
  39. 39.
    Haentjens P, Autier P, Barette M, Boonen S (2001) The economic cost of hip fractures among elderly women. A one-year, prospective, observational cohort study with matched-pair analysis. Belgian Hip Fracture Study Group. J Bone Joint Surg Am 83-A:493–500Google Scholar
  40. 40.
    Gabriel SE, Tosteson AN, Leibson CL, Crowson CS, Pond GR, Hammond CS, et al (2002) Direct medical costs attributable to osteoporotic fractures. Osteoporos Int 13:323–330CrossRefPubMedGoogle Scholar
  41. 41.
    Wiktorowicz ME, Goeree R, Papaioannou A, Adachi JD, Papadimitropoulos E (2001) Economic implications of hip fracture: health service use, institutional care and cost in Canada. Osteoporos Int 12:271–278CrossRefPubMedGoogle Scholar
  42. 42.
    Szucs TD, Häuselmann HJ (2000) Die Wirtschaftlichkeit von Alendronat in der Behandlung der postmenopausalen Osteoporose. Gesundh Ökon Qual Manag 5:99–106Google Scholar
  43. 43.
    Johnell O, Gullberg B, Allander E, Kanis JA (1992) The apparent incidence of hip fracture in Europe: a study of national register sources. MEDOS Study Group. Osteoporos Int 2:298–302PubMedGoogle Scholar
  44. 44.
    Wasnich RD (1997) Epidemiology of osteoporosis in the United States of America. Osteoporos Int 7 [Suppl 3]:S68–72Google Scholar
  45. 45.
    Phillips S, Ray NF, Jacobs J, Wright WE (1988) The direct medical costs of osteoporosis for American women aged 45 and older, 1986. Bone 9:271–279CrossRefPubMedGoogle Scholar
  46. 46.
    Diamond TH, Thornley SW, Sekel R, Smerdely P (1997) Hip fracture in elderly men: prognostic factors and outcomes. Med J Aust 167:412–415PubMedGoogle Scholar
  47. 47.
    Oskam J, Kingma J, Klasen HJ (1998) Fracture of the distal forearm: epidemiological developments in the period 1971–1995. Injury 29:353–355CrossRefPubMedGoogle Scholar

Copyright information

© International Osteoporosis Foundation and National Osteoporosis Foundation 2004

Authors and Affiliations

  • Matthias Schwenkglenks
    • 1
    • 2
  • Kurt Lippuner
    • 3
  • Hans Jörg Häuselmann
    • 4
  • Thomas D. Szucs
    • 2
  1. 1.ECPM Executive OfficeUniversity HospitalBasleSwitzerland
  2. 2.European Center of Pharmaceutical MedicineUniversity of BaselBasleSwitzerland
  3. 3.Osteoporosis UnitInselspitalBerneSwitzerland
  4. 4.Centre of Rheumatology and Bone DiseasesKlinik Im ParkZurichSwitzerland

Personalised recommendations